Conceptio › Archive › Europe PMC
Europe PMCopen access

Depemokimab: A twice yearly anti-IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) - A narrative review

Park MJ et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
Eosinophil, IL-5, Biologics, Mepolizumab, Crswnp, Type 2 Inflammation
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 266489
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.